Novartis receives FDA approval for Arcapta™ Neohaler™, a novel once-daily bronchodilator for chronic obstructive pulmonary disease
Source URL: https://qa1.novartis.us/news/media-releases/novartis-receives-fda-approval-arcaptatm-neohalertm-novel-once-daily-bronchodilator-chronic-obstructive-pulmonary-disease-0
List of links present in page
- https://qa1.novartis.us/news/media-releases/novartis-receives-fda-approval-arcaptatm-neohalertm-novel-once-daily-bronchodilator-chronic-obstructive-pulmonary-disease-0